How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?
Abstract Objectives We conducted a multi-stakeholder survey to determine key areas where a joint European health technology assessment (HTA) could provide ‘additional benefit’ compared to the status quo of many parallel independent national and subnational assessments. Methods Leveraging three itera...
Main Authors: | Elaine Julian, Fabrizio Gianfrate, Oriol Sola-Morales, Peter Mol, Jean-François Bergmann, Tomas Salmonson, Ansgar Hebborn, Mathilde Grande, Jörg Ruof |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Health Economics Review |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13561-022-00379-7 |
Similar Items
-
Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European access academy
by: Elaine Julian, et al.
Published: (2022-11-01) -
Technology Assessment vs. Technology Appraisal—How to Strengthen the Science/Value Dichotomy with EU HTA?
by: Sandro Gsteiger, et al.
Published: (2024-11-01) -
Snake Oil or Super Drug: How Have Regulators and Payers Perceived New Medicines that Target Asymptomatic Conditions?
by: Brian Richard Needham
Published: (2023-11-01) -
What is needed to successfully implement the EU HTA Regulation enabling broad patient access in Europe
by: Oriol Solà-Morales, et al.
Published: (2025-01-01) -
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy
by: Elaine Julian, et al.
Published: (2024-06-01)